Literature DB >> 18153372

Rift Valley fever; accidental infections among laboratory workers.

K C SMITHBURN, A F MAHAFFY.   

Abstract

Entities:  

Keywords:  HEPATITIS

Mesh：

Substances：

Year:  1949        PMID： 18153372

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  29 in total

1.  Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens.

Authors:  C A Le Roux; T Kubo; A A Grobbelaar; P Jansen van Vuren; J Weyer; L H Nel; R Swanepoel; K Morita; J T Paweska
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

Review 2.  Incubation periods of mosquito-borne viral infections: a systematic review.

Authors:  Kara E Rudolph; Justin Lessler; Rachael M Moloney; Brittany Kmush; Derek A T Cummings
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

3.  Risk factors for severe Rift Valley fever infection in Kenya, 2007.

Authors:  Amwayi S Anyangu; L Hannah Gould; Shahnaaz K Sharif; Patrick M Nguku; Jared O Omolo; David Mutonga; Carol Y Rao; Edith R Lederman; David Schnabel; Janusz T Paweska; Mark Katz; Allen Hightower; M Kariuki Njenga; Daniel R Feikin; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

4.  Development of a novel nonhuman primate model for Rift Valley fever.

Authors:  Darci R Smith; Brian H Bird; Bridget Lewis; Sara C Johnston; Sarah McCarthy; Ashley Keeney; Miriam Botto; Ginger Donnelly; Joshua Shamblin; César G Albariño; Stuart T Nichol; Lisa E Hensley
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 5.  Rift Valley Fever.

Authors:  Amy Hartman
Journal:  Clin Lab Med       Date:  2017-03-22       Impact factor: 1.935

6.  A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.

Authors:  David H Holman; Adam Penn-Nicholson; Danher Wang; Jan Woraratanadharm; Mary-Katherine Harr; Min Luo; Ellen M Maher; Michael R Holbrook; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

7.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

8.  Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique.

Authors:  B Niklasson; J Liljestrand; S Bergström; C J Peters
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

9.  Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate.

Authors:  Devin A Boyles; Madeline M Schwarz; Joseph R Albe; Cynthia M McMillen; Katherine J O'Malley; Douglas S Reed; Amy L Hartman
Journal:  J Gen Virol       Date:  2021-02       Impact factor: 3.891

10.  Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13.

Authors:  Boitumelo Moetlhoa; Leeann Naicker; Rose Hayeshi; Anne Grobler; Nobalanda B Mokoena; Crispen Mawadza
Journal:  Access Microbiol       Date:  2020-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.